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Foreword
Traditional medicine has, since its inception, registered numerous examples of treat-
ment resulting in positive or negative outcomes, depending on the patient. This 
observation was reinforced after the completion of the human genome sequencing 
project. As it turns out, individual humans exhibit genetic differences despite pos-
sessing the same genome. The identification of so-called single nucleotide polymor-
phisms confirms and explains the familiar phenomenon of variable reaction to treat-
ment [1, 2]. Given that even siblings differ in terms of their chromosomal material, 
the genetic variability of the general human population should come as no surprise. 
Recent research has also revealed differences in the composition of gut bacterial flora 
resulting from diverse dietary habits [3]. In light of such specificities, the need for 
individual, personalized therapy becomes evident. Fortunately, many high-tech tools 
can be used in medical practice (Chapter 1).
The most direct applications of personalized medicine involve individualized 
pharmacotherapy. Drugs designed to interact with a specific target may help improve 
therapeutic outcomes while remaining affordable, particularly in the presence of bio-
informatic technologies. Identifying links between molecular chemistry and patho-
logical processes is among the goals of system biology [4]. Access to computer soft-
ware that simulates the complete proteome may help discover causal reactions—not 
just in the scope of a particular disease, but between seemingly unconnected pro-
cesses occurring in the organism [4]. Harnessing the power of modern computers 
in an objective, dispassionate therapeutic process will enhance the capabilities of 
medical practitioners, for example, by offering access to vast databases of biologi-
cal and medical knowledge (Chapter 2). Moreover, processing data with the use of 
artificial intelligence algorithms may lead to conclusions which a human would not 
otherwise be able to reach (Chapter 2).
Closer collaboration between communication system experts and biologists 
should help identify promising research directions and explain the methods by 
which organisms—the most complex biological systems known to man—identify and 
process information (Chapter 3).
Gaining insight into the molecular phenomena will help resolve some long-stand-
ing fundamental questions. Even before this happens, however, medical science can 
reap benefits by exploiting existing solutions and models (Chapter 4). 
Eliminating transplant rejection is of critical importance in individualized 
therapy. Three-dimensional bioprinting technologies represent an important mile-
stone on this path (Chapter 5). They can be used to build arbitrarily complex objects, 
with local variations in the applied materials. An advanced printing environment may 
enable introduction of biological material (e.g., cells harvested from the patient for 
whom the implant is being created) directly at the printing stage (Chapter 5). Simi-
larly, the shape of the printed tissue may accurately reflect the patient’s needs, which 
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is particularly important, e.g., when recreating the layout of coronary vessels for 
bypass surgery.
Surgeons may also benefit greatly from the use of robots that surpass humans in 
their capacity to perform repetitive actions with great accuracy (Chapter 6).
Modern diagnostic tools that both simplify the therapeutic process and improve 
its accuracy already provide added value for doctors. A hybrid operating room that 
supports both macro- and microscale (cellular) activities enhances on-the-fly deci-
sion making during surgery (Chapter 7).
Recent advances in augmented reality technologies are finding their way into the 
operating theater, assisting surgeons and enabling them to make the right choices 
as the surgery progresses. Holographically superimposing imaging results (such as 
CAT scans) on the actual view of the patient’s body (made possible by AR headsets) 
enhances the surgeon’s precision and eliminates errors caused by inaccurate identifi-
cation of the surgical target (Chapters 8 and 9).
The use of computers in medical research also encompasses the organization 
system of a hospital. The software monitoring information and transport of materials 
(as well as medical equipment) in hospital units delivers the logistic system for the 
communication of patients and doctors in medical practice (Chapter 10).
The medical treatment takes advantage of applying the techniques of telecom-
munication, allowing the conduct of therapy and especially surgery independently 
between medical doctors participating in the therapeutic practice from a distance 
(Chapter 11). 
Medical education implements the training simulation using phantoms. The 
computer-based steering of phantom behavior allows the medical students to be 
familiar with the patient’s behavior in extreme conditions, conscienceless, or rising 
emotions (Chapter 12). 
This publication should be regarded as an extension of our previous work, pre-
senting the use of simulation techniques in studying systems of variable structural 
complexity (including the human organism [5]). The overview presented simulations 
carried out at several scales, from individual molecules, through cells and organs, all 
the way to the organism as a whole.
The simulation of diagnostic processes is presented with the use of so-called 
virtual patients, whereas therapeutic approaches are discussed on the example of 
chemotherapy. We also present psychological aspects related to gamification and 
describe 3D printing as a means of treating skeletal defects. In this hierarchy of ever-
greater involvement of IT technologies, the final tier is occupied by telemedicine. All 
tiers are discussed against the backdrop of preclinical activities described in the pre-
vious edition of Simulations in Medicine.
The current overview focuses on the use of simulation techniques in clinical 
practice and decision support, particularly in delivering personalized therapeutic 
solutions. Personalized therapy is currently the focus of significant research effort in 
areas such as genomics, epigenetics, drug design, and nutrition, while also yielding 
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practical benefits, such as those described in the presented work. The subject has 
engendered numerous publications, some of which are explicitly mentioned in our 
study.
Both editions of Simulations in Medicine demonstrate the extensive practical 
applications of in silico solutions. The marriage of medicine and information science 
promises to result in tools and approaches that facilitate large-scale adoption of per-
sonalized therapy. It seems, however, that the effective design of personalized treat-
ment options calls for better understanding of processes such as protein folding and 
3D structure prediction. Pathologies that affect the folding process lead to a variety 
of medical conditions jointly referred to as misfolding diseases. This phenomenon is 
among the most pressing challenges facing modern medical research [6–18]. 
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